News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Allison Betof Warner: The TIL team at Stanford Cancer Institute did our first surgical tumor harvest for AMTAGVI (lifileucel) this morning!
Photo taken from Allison Betof Warner/X
Feb 23, 2024, 17:44

Allison Betof Warner: The TIL team at Stanford Cancer Institute did our first surgical tumor harvest for AMTAGVI (lifileucel) this morning!

Allison Betof  Warner, Director of Melanoma Medical Oncology and Solid Tumor Cellular Therapy at Stanford Cancer Institute, recently posted on X/Twitter:

“The TIL team at Stanford Cancer Institute did our first surgical tumor harvest for AMTAGVI (lifileucel) this morning! The tumor is en route to Philadelphia for TIL expansion. Incredibly proud of our team for the work we have done to be ready to deliver this therapy ASAP. Cell therapy for solid tumors is HERE!”

Source: Allison Betof Warner/X

Allison Betof Warner Amtagvi (lifileucel) cancer Cell Therapy Melanoma OncoDaily Oncology solid tumors Stanford Cancer Institute TIL
Special Coverage
Blog
Jan 20, 2025, 15:56
Erman Akkus: Downstaging of HCC before liver transplantation
Blog
Jan 20, 2025, 15:45
Chris Weight: Accepting applications for the Cleveland Clinic Urology, Society of Urologic Oncology fellowship program
Blog
Jan 20, 2025, 15:41
Endoscopic Ultrasound Gastroenterostomy versus Duodenal Stenting for Malignant GOO
Science
Jan 20, 2025, 15:25
Tony Hung: A virtual integrative medicine program to improve symptoms and decrease hospitalization
Blog
Jan 20, 2025, 14:46
Gregg Margolis: Three things to read about health policy this week
Blog
Jan 20, 2025, 14:43
Afreen Shariff: Excellent to connect with fellow board members at the ACCC
Dialogues
Jan 20, 2025, 14:32
The Current Situation with Colorectal Cancer in Kazakhstan
Science
Jan 20, 2025, 14:17
Hung Trinh: Bispecific Antibodies in Cancer Therapy
Insight
Jan 20, 2025, 14:16
Amy Moore: Ensuring that all patients benefit from recent scientific advances in lung cancer
Blog
Jan 20, 2025, 14:04
Emily Drake: I finally joined Bluesky
Insight
Jan 20, 2025, 14:03
Richard Sullivan reflects on major issues cancer care faces in radiotherapy
Blog
Jan 20, 2025, 13:56
Kristina Jankovic: FDA approved datopotamab, deruxtecan-dlnk for unresectable, metastatic, HR+ HER2- breast cancer